
- Get in Touch with Us
Last Updated: Apr 25, 2025 | Study Period: 2024-2030
Capnography is the measurement of carbon dioxide (CO 2) concentrations or partial pressures in the breathing gasses. Its primary application has been as a monitoring tool during anesthesia and acute care. It is often depicted as a CO2 graph. The plot may also indicate the inspired CO 2, which is useful when using rebreathing devices. End tidal CO 2 is the measurement made at the end of a breath (exhaling).
The capnogram is a direct monitor of the CO 2 concentration or partial pressure in the breathed and exhaled air, as well as an indirect monitor of the CO 2 partial pressure in the arterial blood. The difference between arterial blood and expired gas in healthy people
The change in partial pressures is relatively modest (normally 4-5 mmHg). The difference between arterial blood and expired gas increases in the presence of most kinds of lung illness and some forms of congenital heart disease (cyanotic lesions), which might be an indicator of new pathology or a change in the cardiovascular-ventilation system.
Although connected, oxygenation and capnography are different aspects in the physiology of breathing. Ventilation is the mechanical process through which the lungs expand and exchange gas quantities, whereas respiration is the exchange of gasses (mostly CO2 and O 2) at the alveolar level.
The process of respiration is separated into two major functions: the removal of CO2 waste and the replenishment of tissues with new O2. The final half of this system is assessed by oxygenation (usually by pulse oximetry). Capnography assesses CO2 removal, which may be more clinically valuable than oxygenation status.
A single breath may be separated into two phases throughout the regular cycle of respiration: inspiration and expiration. The lungs expand as CO2 free gasses enter the lungs at the start of inspiration. The concentration of CO2 that fills the alveoli when it is filled with this fresh gas is dependent on the ventilation of the alveoli and the perfusion (blood flow) that delivers the CO2 for exchange.
As air is driven out of the respiratory system during expiration, the lung capacity decreases. The volume of CO2 expelled at the conclusion of expiration is produced as a byproduct of tissue metabolism throughout the body. The supply of CO2 to the alveoli for exhalation is contingent on an undamaged circulatory system ensuring enough blood flow from tissue to alveoli.
If cardiac output (the amount of blood pumped out of the heart) decreases, so does the capacity to transport CO2, resulting in a lower expired amount of CO2. The connection between cardiac output and tidal CO2 is linear, which means that when cardiac output increases or decreases, the amount of CO2 increases or decreases.
In the same way, the amount of CO2 is controlled. End tidal CO2 monitoring can thus give critical information on the cardiovascular system's integrity, especially how effectively the heart can pump blood.
The amount of CO2 recorded after each breath necessitates an undamaged circulatory system in order to transfer the CO2 to the alveoli, the functional unit of the lungs. The CO2 carried to the lungs gas occupies a specified area that is not involved in gas exchange during phase I of expiration, which is known as dead space.
Expiration phase II occurs when CO2 from the lungs is driven up the respiratory system on its way out of the body, causing air mixing.The functioning alveoli, which are responsible for gas exchange, are formed from the dead space with the air. Phase III is the final section of expiration that solely reflects CO2 from the alveoli and not from the dead space.
In clinical circumstances, these three stages are critical to comprehend since changes in form and absolute values might signal respiratory and/or cardiovascular impairment.Capnographs operate on the premise that CO2 is a polyatomic gas that absorbs infrared light. An infrared laser beam is sent across the gas sample and lands on a sensor.
The presence of CO2 in the atmosphere reduces the quantity of light falling on the sensor, causing the voltage in a circuit to vary. The analysis is quick and precise.
The Global Capnography Monitors Market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.
Covidien, a global leader in healthcare goods and a recognised developer in patient monitoring and respiratory care equipment, introduced the Capnostream 20p bedside monitor today. The new capnography system, which incorporates Covidien's Microstream technology, includes expanded capabilities that will assist physicians in identifying and addressing major health hazards more quickly.
Microstream capnography monitoring has been used by doctors for almost two decades to provide an integrated, full view of oxygenation and breathing. These characteristics can assist doctors in managing sedation levels and ensuring the safe administration of opioids for pain treatment.
The Apnea-Sat Alert algorithm in the Capnostream 20p bedside monitor measures and reports repeated apnea (temporary stopping of breathing for more than 10 seconds) and oxygen desaturation occurrences.Apneic episodes on a regular basis can offer doctors with early warning of cardiopulmonary problems.
Combining the new Apnea-Sat Alert function with Covidien's proven capnography technology may aid in the early diagnosis and treatment of cardiac arrest and other critical disorders.The Apnea-Sat Alert function detects apneas per hour and oxygen desaturation variations and displays the readings on the Capnostream 20p monitor screen without the need for additional equipment or modifications to clinical workflow.
Apnea-Sat Alert technology is part of a larger family of Smart Alarm Management integrated algorithms that assist in reducing alarm fatigue while adhering to Joint Commission alarm management criteria.
Sl no | Topic |
1 | Market Segmentation |
2 | Scope of the report |
3 | Abbreviations |
4 | Research Methodology |
5 | Executive Summary |
6 | Introduction |
7 | Insights from Industry stakeholders |
8 | Cost breakdown of Product by sub-components and average profit margin |
9 | Disruptive innovation in the Industry |
10 | Technology trends in the Industry |
11 | Consumer trends in the industry |
12 | Recent Production Milestones |
13 | Component Manufacturing in US, EU and China |
14 | COVID-19 impact on overall market |
15 | COVID-19 impact on Production of components |
16 | COVID-19 impact on Point of sale |
17 | Market Segmentation, Dynamics and Forecast by Geography, 2024-2030 |
18 | Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030 |
19 | Market Segmentation, Dynamics and Forecast by Application, 2024-2030 |
20 | Market Segmentation, Dynamics and Forecast by End use, 2024-2030 |
21 | Product installation rate by OEM, 2023 |
22 | Incline/Decline in Average B-2-B selling price in past 5 years |
23 | Competition from substitute products |
24 | Gross margin and average profitability of suppliers |
25 | New product development in past 12 months |
26 | M&A in past 12 months |
27 | Growth strategy of leading players |
28 | Market share of vendors, 2023 |
29 | Company Profiles |
30 | Unmet needs and opportunity for new suppliers |
31 | Conclusion |
32 | Appendix |